期刊
CLINICAL PHARMACOLOGY & THERAPEUTICS
卷 98, 期 2, 页码 185-195出版社
WILEY
DOI: 10.1002/cpt.125
关键词
-
资金
- AstraZeneca
- Bristol-Myers Squibb
- Amylin Pharmaceuticals
Adverse iatrogenic effects of especial relevance for antidiabetes medications include hypoglycemic episodes, major adverse cardiovascular (CV) events, cancer, bone fractures, pancreatic effects, genital/urinary tract infections, and weight gain. Here, recent clinical studies addressing safety profiles of antidiabetes medications are reviewed. On balance, new prospective and population-based studies continue to indicate that the benefits of improved glucose control outweigh the risks associated with antidiabetes medications in most patients with type 2 diabetes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据